Burzynski Research Institute, Inc. (BZYR)

Market Cap	3.29M -56.8%
Revenue (ttm)	n/a
Net Income	-1.29M
EPS	-0.01
Shares Out	131.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	15,798
Open	0.0250
Previous Close	0.0250
Day's Range	0.0250 - 0.0250
52-Week Range	0.0170 - 0.0550
Beta	0.29
RSI	47.44
Earnings Date	May 28, 2026

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1977
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BZYR